Correction: Neratinib: Inching up on the cure rate of HER2                         þ                          breast cancer? (Clin Cancer Res) (2019) 24 (3483–3485) Doi: 10.1158/1078-0432.CCR-18-1114)

Nisha Unni; Dhivya R Sudhan; Carlos L. Arteaga

doi:10.1158/1078-0432.CCR-18-4271

Correction: Neratinib: Inching up on the cure rate of HER2 ^þ breast cancer? (Clin Cancer Res) (2019) 24 (3483–3485) Doi: 10.1158/1078-0432.CCR-18-1114)

Nisha Unni
, Dhivya R Sudhan
, Carlos L. Arteaga

Research output: Contribution to journal › Comment/debate › peer-review

Abstract

In the original version of this article (1), the stated disclosure of the author Carlos L. Arteaga is incorrect. The error has been corrected in the latest online HTML and PDF versions of the article. The authors regret this error.

Original language	English (US)
Pages (from-to)	1430
Number of pages	1
Journal	Clinical Cancer Research
Volume	25
Issue number	4
DOIs	https://doi.org/10.1158/1078-0432.CCR-18-4271
State	Published - Feb 15 2019

ASJC Scopus subject areas

Oncology
Cancer Research

Access to Document

10.1158/1078-0432.CCR-18-4271

Cite this

Correction: Neratinib: Inching up on the cure rate of HER2 ^þ breast cancer? (Clin Cancer Res) (2019) 24 (3483–3485) Doi: 10.1158/1078-0432.CCR-18-1114). / Unni, Nisha; Sudhan, Dhivya R; Arteaga, Carlos L.
In: Clinical Cancer Research, Vol. 25, No. 4, 15.02.2019, p. 1430.

Research output: Contribution to journal › Comment/debate › peer-review

@article{2850998a4f904f78abd60f5f90ef4f95,

title = "Correction: Neratinib: Inching up on the cure rate of HER2 {\th} breast cancer? (Clin Cancer Res) (2019) 24 (3483–3485) Doi: 10.1158/1078-0432.CCR-18-1114)",

abstract = "In the original version of this article (1), the stated disclosure of the author Carlos L. Arteaga is incorrect. The error has been corrected in the latest online HTML and PDF versions of the article. The authors regret this error.",

author = "Nisha Unni and Sudhan, \{Dhivya R\} and Arteaga, \{Carlos L.\}",

note = "Publisher Copyright: {\textcopyright} 2019 American Association for Cancer Research.",

year = "2019",

month = feb,

day = "15",

doi = "10.1158/1078-0432.CCR-18-4271",

language = "English (US)",

volume = "25",

pages = "1430",

journal = "Clinical Cancer Research",

issn = "1078-0432",

publisher = "American Association for Cancer Research Inc.",

number = "4",

}

TY - JOUR

T1 - Correction

T2 - Neratinib: Inching up on the cure rate of HER2 þ breast cancer? (Clin Cancer Res) (2019) 24 (3483–3485) Doi: 10.1158/1078-0432.CCR-18-1114)

AU - Unni, Nisha

AU - Sudhan, Dhivya R

AU - Arteaga, Carlos L.

PY - 2019/2/15

Y1 - 2019/2/15

N2 - In the original version of this article (1), the stated disclosure of the author Carlos L. Arteaga is incorrect. The error has been corrected in the latest online HTML and PDF versions of the article. The authors regret this error.

AB - In the original version of this article (1), the stated disclosure of the author Carlos L. Arteaga is incorrect. The error has been corrected in the latest online HTML and PDF versions of the article. The authors regret this error.

UR - https://www.scopus.com/pages/publications/85061610057

UR - https://www.scopus.com/pages/publications/85061610057#tab=citedBy

U2 - 10.1158/1078-0432.CCR-18-4271

DO - 10.1158/1078-0432.CCR-18-4271

M3 - Comment/debate

C2 - 30770489

AN - SCOPUS:85061610057

SN - 1078-0432

VL - 25

SP - 1430

JO - Clinical Cancer Research

JF - Clinical Cancer Research

IS - 4

ER -

Correction: Neratinib: Inching up on the cure rate of HER2 ^þ breast cancer? (Clin Cancer Res) (2019) 24 (3483–3485) Doi: 10.1158/1078-0432.CCR-18-1114)

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this